MilliporeSigma

[Not Yet Scheduled]
MilliporeSigma is the life science business of Merck KGaA, Darmstadt, Germany, one of the world’s leading science and technology companies, bringing together world-class products and services as well as contract development and manufacturing services (CDMO) across traditional and novel modalities.

Our full-service biologic CDMO branch supports biotech companies, who decide to outsource their biologic drug development, providing deep expertise and flexible solutions in alignment with their specific program and funding milestones. We establish customer-centric, agile partnerships with start-up biotechs to help them navigate the various stages of process development, as well as chemistry, manufacturing and controls (CMC), filing and regulatory affairs.

We are expanding our capacity of our biologic facility in Burlington, MA, USA and will open a state-of-the art facility for commercial manufacturing of biologics in Martillac, France in Q3 2022.
Ticker:
MRK
Exchange:
Frankfurt, Germany
Company Type:
Publicly Traded Company
Company Website:
Company HQ State:
Massachusetts
Company HQ Country:
United States
Year Founded:
Not Provided
Main Therapeutic Focus:
Lead Product in Development:
N/A
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):
Not Provided